Recent Company News

• 02:40 PM ET Aug 21, 2026
  

  Follow-up: Empaveli label updated to describe additional benefit within existing indication ($217.00, +2.65)

• 02:06 AM ET Aug 10, 2026
  

  Swedish Orphan Biovitrum, Innate Pharma enter strategic partnership to enable initiation of TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma (SEK 453.20, 0.00)

• 04:43 PM ET Aug 03, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:45 AM ET Aug 03, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:11 AM ET Aug 03, 2026
  

  BioNTech designated CEO Ugur Sahin steps down; appoints Guido Oelkers as new CEO from 1-Feb-27 ($90.58, 0.00)

• 03:50 AM ET Jul 17, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:49 AM ET Aug 03, 2026
  

  StreetAccount Summary - European pre-market trading update

• 07:08 PM ET Jul 21, 2026
  

  President Trump states tariff on generic drugs will stay at 0% for 2 years then rise to 100% - Truth Social

• 12:36 AM ET Jul 17, 2026
  

  Swedish Orphan Biovitrum downgraded to hold from buy at DNB Carnegie (SEK 465.80, 0.00)